Last Updated: September 24, 2026

MIACALCIN Drug Patent Profile

Name: MIACALCIN Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Miacalcin, and what generic alternatives are available?

Miacalcin is a drug marketed by Mylan Ireland Ltd and Saptalis Pharms and is included in two NDAs.

The generic ingredient in MIACALCIN is calcitonin salmon. There is one drug master file entry for this compound. Eleven suppliers are listed for this compound. Additional details are available on the calcitonin salmon profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for MIACALCIN?
What are the global sales for MIACALCIN?
What is Average Wholesale Price for MIACALCIN?

Summary for MIACALCIN

US Patents:	0
Applicants:	2
NDAs:	2
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	1
Clinical Trials:	4
Drug Prices:	Drug price information for MIACALCIN
What excipients (inactive ingredients) are in MIACALCIN?	MIACALCIN excipients list
DailyMed Link:	MIACALCIN at DailyMed

Drug patent expirations by year for MIACALCIN

Recent Clinical Trials for MIACALCIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Missouri-Columbia	Phase 4
ProMedica Health System	Phase 4
University of Toledo Health Science Campus	Phase 4

See all MIACALCIN clinical trials

Pharmacology for MIACALCIN

Drug Class	Calcitonin

US Patents and Regulatory Information for MIACALCIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan Ireland Ltd	MIACALCIN	calcitonin salmon	INJECTABLE;INJECTION	017808-001	Jul 3, 1986		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Mylan Ireland Ltd	MIACALCIN	calcitonin salmon	INJECTABLE;INJECTION	017808-002	Mar 29, 1991	AP	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Saptalis Pharms	MIACALCIN	calcitonin salmon	SPRAY, METERED;NASAL	020313-002	Aug 17, 1995		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for MIACALCIN

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Saptalis Pharms	MIACALCIN	calcitonin salmon	SPRAY, METERED;NASAL	020313-002	Aug 17, 1995	⤷ Start Trial	⤷ Start Trial
Saptalis Pharms	MIACALCIN	calcitonin salmon	SPRAY, METERED;NASAL	020313-002	Aug 17, 1995	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for MIACALCIN

See the table below for patents covering MIACALCIN around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Austria	394947		⤷ Start Trial
Austria	402895		⤷ Start Trial
Austria	A259288		⤷ Start Trial
Austria	A349483		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.